Ingenol mebutate gel

DRUG2 trials

Sponsors

LEO Pharma, Instituto Nacional de Cancer, Brazil

Conditions

Actinic CheilitisActinic Keratosis

Phase 1

Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis

CompletedNCT01820260

LEO PharmaActinic Keratosis

Start: 2013-04-30End: 2014-08-31Updated: 2025-03-13

Evaluation of Ingenol Mebutate for Actinic Cheilitis Treatment

WithdrawnNCT03452566

Instituto Nacional de Cancer, BrazilActinic Cheilitis

Start: 2020-02-29End: 2022-04-30Updated: 2019-06-19